• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浆液性液体细胞学的最佳体积评估

Optimal Volume Assessment for Serous Fluid Cytology.

作者信息

Christofidis Konstantinos, Theochari Maria, Mavropoulos Papoudas Stylianos, Kiohou Lamprini, Sousouris Stylianos, Dimitriadou Areti, Volakakis Nikolaos, Maounis Nicoletta, Mikou Panagiota

机构信息

Cytopathology Laboratory, "Laiko" General Hospital of Athens, 11527 Athens, Greece.

Oncology Unit, "Hippokration" General Hospital of Athens, 11527 Athens, Greece.

出版信息

Biomedicines. 2024 Apr 18;12(4):899. doi: 10.3390/biomedicines12040899.

DOI:10.3390/biomedicines12040899
PMID:38672252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11048718/
Abstract

OBJECTIVE

This study aimed to investigate the optimal volume of serous fluid needed for accurate diagnosis using The International System for Reporting Serous Fluid Cytopathology (TIS), as well as to provide information on the distribution of serous effusion cases in the TIS categories (ND: non-diagnostic, NFM: negative for malignancy, AUS: atypia of undetermined significance, SFM: suspicious for malignancy, MAL: malignant) and relevant epidemiological data.

METHODS

A retrospective analysis of 2340 serous effusion cases (pleural, peritoneal, and pericardial) from two hospitals between 2018 and 2020 was conducted. TIS categories were assigned to each case, and for 1181 cases, these were correlated with the volume of the analyzed fluid.

RESULTS

Our study found statistically significant differences in volume distributions between certain TIS categories. Statistically lower volumes were observed in NFM compared to MAL, in UNCERTAIN (ND, AUS, SFM) compared to both MAL and NFM, and in NOT MAL (ND, NFM, AUS, SFM) compared to MAL. However, these differences were not substantial enough to hold any clinical relevance.

CONCLUSIONS

This study suggests that while fluid volume may slightly influence the TIS category, it does not impact the diagnostic accuracy of serous effusion cytology. Therefore, the ideal serous effusion specimen volume can be defined solely by practical parameters.

摘要

目的

本研究旨在探讨使用国际浆液性液体细胞病理学报告系统(TIS)进行准确诊断所需的最佳浆液性液体量,以及提供浆液性积液病例在TIS分类(ND:非诊断性,NFM:恶性阴性,AUS:意义未明的非典型性,SFM:恶性可疑,MAL:恶性)中的分布信息及相关流行病学数据。

方法

对2018年至2020年期间两家医院的2340例浆液性积液病例(胸腔、腹腔和心包腔)进行回顾性分析。为每个病例指定TIS分类,对于1181例病例,将这些分类与分析的液体量相关联。

结果

我们的研究发现某些TIS分类之间在液体量分布上存在统计学显著差异。与MAL相比,NFM中的液体量在统计学上较低;与MAL和NFM相比,UNCERTAIN(ND、AUS、SFM)中的液体量在统计学上较低;与MAL相比,NOT MAL(ND、NFM、AUS、SFM)中的液体量在统计学上较低。然而,这些差异不足以具有任何临床相关性。

结论

本研究表明,虽然液体量可能会对TIS分类产生轻微影响,但它不会影响浆液性积液细胞学的诊断准确性。因此,理想的浆液性积液标本量可以仅由实际参数来定义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/edebad64e7a0/biomedicines-12-00899-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/2c82cd77288b/biomedicines-12-00899-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/9e995a339669/biomedicines-12-00899-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/cb81c0564894/biomedicines-12-00899-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/8c991ab41e40/biomedicines-12-00899-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/b379844dd98a/biomedicines-12-00899-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/edebad64e7a0/biomedicines-12-00899-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/2c82cd77288b/biomedicines-12-00899-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/9e995a339669/biomedicines-12-00899-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/cb81c0564894/biomedicines-12-00899-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/8c991ab41e40/biomedicines-12-00899-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/b379844dd98a/biomedicines-12-00899-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbe7/11048718/edebad64e7a0/biomedicines-12-00899-g006.jpg

相似文献

1
Optimal Volume Assessment for Serous Fluid Cytology.浆液性液体细胞学的最佳体积评估
Biomedicines. 2024 Apr 18;12(4):899. doi: 10.3390/biomedicines12040899.
2
The International System for Reporting Serous Fluid Cytopathology: An Institutional Experience on its Implication and Assessment of Risk of Malignancy in Effusion Cytology.国际浆液性液体细胞病理学报告系统:关于其在积液细胞学中恶性风险评估及意义的机构经验
J Cytol. 2023 Oct-Dec;40(4):159-164. doi: 10.4103/joc.joc_111_22. Epub 2023 Oct 16.
3
Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.国际浆膜腔液细胞病理学报告系统(TIS)的应用:一项回顾性机构研究。
Cytopathology. 2022 May;33(3):305-311. doi: 10.1111/cyt.13113. Epub 2022 Mar 7.
4
Risk of Malignancy in Effusions according to the International System for Serous Fluid Cytopathology: A Review.根据国际浆膜腔液细胞病理学系统评估渗出液中的恶性肿瘤风险:综述。
Acta Cytol. 2024;68(4):384-393. doi: 10.1159/000540414. Epub 2024 Jul 18.
5
Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.国际浆膜腔液细胞学报告系统(ISRSFC)在积液标本中的应用——一项肿瘤学环境中的前瞻性研究。
J Am Soc Cytopathol. 2023 Sep-Oct;12(5):351-361. doi: 10.1016/j.jasc.2023.04.005. Epub 2023 May 3.
6
Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.国际浆膜腔液细胞病理学报告系统对不同浆膜腔积液良恶性病因的综合评估:台湾的一项多机构研究。
Cancer Cytopathol. 2024 Mar;132(3):169-178. doi: 10.1002/cncy.22783. Epub 2023 Dec 8.
7
A retrospective analysis of serous effusions based on the newly proposed international system for reporting serous fluid cytopathology: a report of 3633 cases in an oncological center.基于新提出的国际浆膜腔液细胞学报告系统的浆膜腔积液回顾性分析:肿瘤中心 3633 例病例报告。
Diagn Pathol. 2022 Jul 2;17(1):56. doi: 10.1186/s13000-022-01241-4.
8
Role of Ancillary Techniques in Reporting Serous Fluid Cytology - "Redefining Categories, Refining Diagnosis".辅助技术在浆液性液体细胞学报告中的作用——“重新定义类别,优化诊断”
J Cytol. 2024 Apr-Jun;41(2):96-104. doi: 10.4103/joc.joc_114_23. Epub 2024 Apr 24.
9
Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.使用国际浆膜腔液细胞病理学报告系统对浆膜腔积液进行分类,并评估诊断准确性的恶性肿瘤风险。
Cytopathology. 2022 Mar;33(2):176-184. doi: 10.1111/cyt.13089. Epub 2021 Dec 28.
10
Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.国际浆膜腔液细胞病理学报告系统在心包液中的应用:不明确诊断的根本原因分析、细胞组织学相关性及恶性风险评估。
Cancer Cytopathol. 2023 Jul;131(7):433-441. doi: 10.1002/cncy.22696. Epub 2023 Mar 27.

引用本文的文献

1
Not Enough Cells: How Insufficient Cytological Specimens Are Mirrored by Reporting Systems - Journey from the Bethesda to the WHO Reporting Systems.细胞数量不足:报告系统如何反映细胞学标本不足——从贝塞斯达报告系统到世界卫生组织报告系统的历程
Acta Cytol. 2025 Jun 17:1-12. doi: 10.1159/000546947.

本文引用的文献

1
Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.国际浆膜腔液细胞病理学报告系统对不同浆膜腔积液良恶性病因的综合评估:台湾的一项多机构研究。
Cancer Cytopathol. 2024 Mar;132(3):169-178. doi: 10.1002/cncy.22783. Epub 2023 Dec 8.
2
Review of the impact of the International System for Serous Fluid Cytopathology.浆液性液体细胞病理学国际系统的影响综述
Cytopathology. 2024 Jan;35(1):16-22. doi: 10.1111/cyt.13313. Epub 2023 Oct 5.
3
Optimal fluid volume for detecting malignancy in serous effusions: a single institution experience.
浆膜腔积液中检测恶性肿瘤的最佳液体量:单中心经验。
J Am Soc Cytopathol. 2023 Nov-Dec;12(6):415-422. doi: 10.1016/j.jasc.2023.06.003. Epub 2023 Jun 13.
4
Reassessing the optimal volume for malignancy detection in serous fluid cytology.重新评估浆膜腔积液细胞学检查中恶性肿瘤检测的最佳容量。
Cancer Cytopathol. 2022 Jul;130(7):551-557. doi: 10.1002/cncy.22577. Epub 2022 Apr 25.
5
Adequacy in pleural effusion: What is the minimum volume required for detection of malignant cells?胸腔积液的充足性:检测恶性细胞所需的最小体积是多少?
Diagn Cytopathol. 2022 Jun;50(6):284-288. doi: 10.1002/dc.24959. Epub 2022 Apr 1.
6
Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.国际浆膜腔液细胞病理学报告系统(TIS)的应用:一项回顾性机构研究。
Cytopathology. 2022 May;33(3):305-311. doi: 10.1111/cyt.13113. Epub 2022 Mar 7.
7
How much is enough: investigation of pleural fluid cytology findings related to sample volume.
J Am Soc Cytopathol. 2022 Mar-Apr;11(2):94-101. doi: 10.1016/j.jasc.2021.12.002. Epub 2021 Dec 17.
8
Application of the International System for Reporting Serous Fluid Cytopathology with Cytohistological Correlation and Risk of Malignancy Assessment.国际浆液性液体细胞病理学报告系统在细胞组织学相关性及恶性风险评估中的应用
Diagnostics (Basel). 2021 Nov 28;11(12):2223. doi: 10.3390/diagnostics11122223.
9
Serous fluid cytopathology: Past, present, and future.浆膜腔液细胞学诊断:过去、现在和未来。
Diagn Cytopathol. 2021 May;49(5):577-581. doi: 10.1002/dc.24663. Epub 2021 Feb 26.
10
Suspicious for Malignancy Diagnoses on Pleural Effusion Cytology.胸腔积液细胞学检查疑恶性诊断。
Am J Clin Pathol. 2020 Aug 5;154(3):394-402. doi: 10.1093/ajcp/aqaa058.